Clinical Trial Update: Efavirenz for the Treatment of Creutzfeldt-Jakob Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of efavirenz for Creutzfeldt-Jakob disease is listed, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Creutzfeldt-jakob Disease

Drugs mentioned

• efavirenz (Sustiva) (efavirenz)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Creutzfeldt-Jakob Disease | Phase 3 | Status: NOT_YET_RECRUITING